These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Salzer W Perit Dial Int; 2005; 25(4):313-9. PubMed ID: 16022084 [TBL] [Abstract][Full Text] [Related]
5. Current and new antimicrobial agents. Eliopoulos GM Am Heart J; 2004 Apr; 147(4):587-92. PubMed ID: 15077072 [TBL] [Abstract][Full Text] [Related]
6. Treatment of infections caused by resistant Staphylococcus aureus. Anstead GM; Quinones-Nazario G; Lewis JS Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681 [TBL] [Abstract][Full Text] [Related]
10. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients? Kan GW; Thomas MA; Heath CH Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens]. Manfredi R Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159 [TBL] [Abstract][Full Text] [Related]
12. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis? Hansson JH Semin Dial; 2011; 24(4):449-50. PubMed ID: 21851410 [No Abstract] [Full Text] [Related]
13. [New anti-Gram+antibiotics: which role in infective endocarditis?]. Makinson A; Le Moing V Ann Cardiol Angeiol (Paris); 2008 Apr; 57(2):88-92. PubMed ID: 18395180 [TBL] [Abstract][Full Text] [Related]
14. [Staphylococcus aureus and antibiotic resistance]. Sancak B Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792 [TBL] [Abstract][Full Text] [Related]
15. Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center. Oliveira LG; Luengo J; Caramori JC; Montelli AC; Cunha Mde L; Barretti P Int Urol Nephrol; 2012 Oct; 44(5):1529-37. PubMed ID: 22302733 [TBL] [Abstract][Full Text] [Related]
16. New antibiotic agents: problems and prospects. Weber DJ; Rutala WA Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500 [TBL] [Abstract][Full Text] [Related]
17. Successful salvage of peritoneal catheter in unresolved methicillin-resistant staphylococcus aureus peritonitis by combination treatment with daptomycin and rifampin. Lin SY; Ho MW; Liu JH; Liu YL; Yeh HC; Hsieh TL; Wang IK; Lin HH; Huang CC Blood Purif; 2011; 32(4):249-52. PubMed ID: 21846982 [TBL] [Abstract][Full Text] [Related]
18. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733 [TBL] [Abstract][Full Text] [Related]
19. Novel antibacterial agents for skin and skin structure infections. Schweiger ES; Weinberg JM J Am Acad Dermatol; 2004 Mar; 50(3):331-40; quiz 341-2. PubMed ID: 14988672 [TBL] [Abstract][Full Text] [Related]